Awareness of Iron Status Evaluation in UGIB

BACKGROUND: Data on the awareness of the need to evaluate iron status and IDA prevalence in acute UGIB are limited.

OBJECTIVES: This study aimed to investigate the rate of evaluation of iron status and prevalence of iron deficiency anemia (IDA) and the associated factors in patients with anemia hospitalized for acute upper gastrointestinal bleeding (UGIB).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Upper Gastrointestinal Bleeding Anemia Digestive System Diseases Gastrointestinal Diseases Gastrointestinal Hemorrhage Hematologic Diseases Hemic and Lymphatic Diseases Hemorrhage Iron Deficiencies Iron Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hatyai Hospital

Hat Yai, Changwat Songkhla, 90110, Thailand

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients > 18 years of age who were admitted because of acute UGIB and were diagnosed with anemia from UGIB during hospitalization.

Exclusion criteria

patients who had previously undergone endoscopy at another institution before admission
patients who had a definite cause of UGIB that was inconclusive
incomplete data for analysis.

Treatment and study plan

Primary outcomes

iron status measurement

Time frame: During admission

iron status measurement during admission among patients hospitalized for acute UGIB.

Secondary outcomes

Iron deficiency anemia

Time frame: During admission

patients with anemia who had serum ferritin < 30 μg/L and/or transferrin saturation < 16%.

Sponsors and collaborators

Lead sponsor

Hat Yai Medical Education Center

Other

Registry information

Official study title

Awareness of the Need for the Evaluation of Iron Status Among Hospitalized Patients With Acute Upper Gastrointestinal Bleeding.

Acronym: AISE

Important dates

Study start: 2023
Primary completion: 2023
Study completion: 2023
First posted: Mar 7, 2024
Registry last updated: Mar 7, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed